This latest patent enhances the company’s ever-expanding catalogue of proprietary technology, further cementing its global reputation as an innovator in the advancement of healthcare while making access to premium-quality craniomaxillofacial implants faster, easier, and more affordable.

Poriferous manufactures SuᐧPor implants using biocompatible, porous polyethylene. The material creates an interconnecting, omnidirectional pore structure that promotes fibrovascular ingrowth and integration with patient tissue for lasting results.